What is the main business of Upgrow?

The main business activity of Upgrow focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on April 4, 2022.

Where is the headquarters located?

The headquarters is located at: ul. Ilji Miecznikowa 1, 02-096 Warszawa.

Who is on the management board?

The management board consists of: Paweł Aleksander Siedlecki (President of the Management Board) and Rafał Piotr Archacki (Member of the Management Board).

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

In 2024, the company generated total revenue of $10,273, representing a decrease of 27.5% compared to 2023.

Yes, the company recorded a net profit of $593 in 2024, meaning the company decreased its profit by 94.1%.

Which cost dominates operating expenses?

The largest operating cost category falls under employee remuneration. This category amounted to $8,770 in 2024, representing 91% of all operating expenses.

Upgrowsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2022-04-04

Share capital

5,000.00 PLN

Registered address

ul. Ilji Miecznikowa 1/309c, 02-096 Warszawa, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed.

2025not filed
202410/07/2025
202309/07/2024
202210/07/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Research and experimental development on biotechnology254 / 386

Top 66%

Division · Scientific research and development1,411 / 1,953

Top 72%

Sector · Professional, scientific and technical activities31,825 / 39,213

Top 81%

Voivodeship · Mazowieckie114,060 / 142,033

Top 80%

Country · Poland407,157 / 495,860

Top 82%

Results vs industry

Revenue

This companyUSD 10.27kMedianUSD 55.24kAverageUSD 2.70m

Net profit

This companyUSD 593.02MedianUSD -1.27kAverageUSD -92.18k

Operating costs

This companyUSD 9.61kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 11.93kMedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Paweł Aleksander Siedlecki – President of the Management Board

Rafał Piotr Archacki – Management Board Member

Manner of representation

In the case of a multi-member management board, two members of the management board acting jointly are authorized to make declarations of will and sign documents on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Rafał Piotr Archackiage 45	39	$526.74	39%
Grzegorz Andrzej Banaśage 41	12	$162.07	12%
Paweł Aleksander Siedleckiage 50	39	$526.74	39%
Uwrc sp. z o.o.	10	$135.06	10%

Beneficial owners

Person	Rights

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Frontline BiosciencesS.A.	$219,186.29	frontlinebiosciences.com
AI Corelabsp. z o.o.	$128,365.55	aicorelab.com
ModicaP.S.A.	$103,400.72	modica.bio
WPD Pharmaceuticalssp. z o.o.	$90,822.78	wpdpharmaceuticals.com
WPD PharmaceuticalsS.A.	$87,561.70	wpdpharmaceuticals.pl
Stenocoatsp. z o.o.	$36,665.21	stenocoat.com
Platforma Badań Genetycznychsp. z o.o.	$28,558.39	zdrowegeny.pl
Bioselsp. z o.o.	$19,100.32	selol.pl
Omnisepticasp. z o.o.	$3,475.29	omniseptica.com
Wavex Energysp. z o.o.	$142.33	wavexenergy.com